niuz

Europa da luz verde a la pastilla diaria que eleva la esperanza de vida a los pacientes con cáncer de páncreas

1 source
One source
What the source said
El Mundo
“Europa da luz verde a la pastilla diaria que eleva la esperanza de vida a los pacientes con cáncer de páncreas”

La Agencia Europea de Medicamentos (EMA) recomienda la autorización de comercialización para Rasonque (daraxonrasib), un fármaco para frenar al adenocarcinoma pancreático metastásico Leer

Read at El Mundo
Is this point wrong? Tell us

Reported by one source so far. It is confirmed when a second, independent source reports the same thing.

How recent

The shading behind a date drains as it ages: full when new, three quarters at 1 hour, half at 6 hours, a quarter at 12 hours, empty after a day. The date is when the source published it.